COVID-19: EFPIA Industry Information
The EFPIA and its member companies and associations are committed to the global fight against the coronavirus pandemic. Click here to learn more.
Search
Corporate Profile
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. Learn more about our company here.
Purchasing
Find out information about Boehringer Ingelheim's purchasing and supplier relationships here, as well as links to useful resources for suppliers too.
World Patient Safety Day 2021
As a sign of support for World Patient Safety Day, Boehringer Ingelheim lights up buildings in orange. Click here to learn and find out more.
Press Releases
Click here to find the latest press releases from Boehringer Ingelheim on animal health, prescription medicine, pipeline and corporate news.
Featured Stories
Click here to see Boehringer Ingelheim's latest featured stories to help provide inspiration for both human and animal health and well-being.
Products
Click here for an overview of our human and animal health products. We provide a wide range of products to help improve the lives of humans and animals.
What is "Social Entrepreneurship?"
Our shared planet faces multiple threats, especially concerning people's health and wellbeing. Learn about how social entrepreneurship can help here.
Boehringer Ingelheim India and Vvaan Lifesciences Pvt Ltd announce strategic distribution partnership to expand pet portfolio reach.
Boehringer Ingelheim India and Vvaan Lifesciences Pvt Ltd announce strategic distribution partnership to expand pet portfolio reach.
Duluth
Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Duluth site.
Boehringer Ingelheim India launches VAXXITEK® HVT + IBD, globally acclaimed single shot poultry vaccine
Boehringer Ingelheim India launches VAXXITEK® HVT + IBD, globally acclaimed single shot poultry vaccine. Click here to find out and learn more information.
COVID-19 USA Double the Impact in the Fight Against COVID-19
Employees can double their impact through the BI Cares Matching Gifts Program. Click here to learn and find out more information about this.
BI India joins forces with PPAM and BMC to Stop Rabies
This initiative will adopt a two-pronged approach of vaccination and education.
NexGard Spectra launched in China
Early August 2018, NexGard Spectra (afoxolaner and milbemycin oxime), the first oral endectocide for dogs, was launched in China. Click here to learn more.
Boehringer Ingelheim allocates COVID relief fund to support underserved communities and patients in India
Boehringer Ingelheim is making available a Euro One Million COVID relief fund to support underserved communities and patients in India. Learn more here.
Collaboration to fight NCDs
70 percent of global deaths are attributable to NCDs and severely impacting on people in low- and middle-income countries. Help is desperately needed.
Our Commitment
We want to create value in areas of unmet medical need and engage with communities and society to improve lives – for humans and animals. Find out more.
International Women's Day
We celebrate International Women’s Day with this year’s UN Women motto being “Gender Equality Today for a Sustainable Tomorrow”. Find out more here.
COVID-Relief-India-2021
Boehringer Ingelheim prioritises life continuity to the underserved, in addition to medical aid. Click here to find out and learn more information.
Boehringer Ingelheim introduces NexGard SPECTRA® for dogs in India
Boehringer Ingelheim introduces NexGard SPECTRA® for dogs in India
COVID-19 General Q&A
Here we provide a list of questions and answers about COVID-19, including what it is, how it spreads, and more. Click here to find out more.
We create Value through Innovation for our customers
We create value through innovation for our customers. Discover how we live our Leitbild. Click here to find out more and to access related articles.
The Core of our Leitbild
Click here to find out about the core of our leitbild. Here you can find out information about who we are and what we strive for at Boehringer Ingelheim.
Boehringer Ingelheim India to sustain growth momentum in 2021, focuses on partnerships in NCD management
Boehringer Ingelheim India to sustain growth momentum in 2021, focuses on partnerships in NCD management. Click here to find out more information.
COVID-19 Boehringer Ingelheim Thailand equips frontline
Boehringer Ingelheim Thailand is working together with the Thai Department of Disease Control during the pandemic. Click here to learn more.